Summary
Updated Aug 31, 2026
Ashish Mandelia is VP, Chief Accounting Officer of Mersana Therapeutics, Inc. (MRSN). 1 SEC Form 4 filing on record, dated 7 October 2024. Most recent open-market trade: sold $7K of MRSN on 7 October 2024. Lifetime open-market sales: $16K.
Recent Transactions
3Every recent SEC Form 4 transaction Ashish Mandelia has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Ashish Mandelia go back to 2024: 1 primary Form 4 filing, an average of 0.3 per year. 4 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Ashish Mandelia files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Martin H. Huber Jr. - $15K of MRSN open-market activity in the last 12 months
- Mohan Bala - $762 of MRSN open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Ashish Mandelia?
Ashish Mandelia is a corporate insider, tracked as VP, Chief Accounting Officer of Mersana Therapeutics, Inc. (MRSN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Ashish Mandelia last file a Form 4?
The only primary Form 4 on record is dated 7 October 2024.
Has Ashish Mandelia been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($16K) across all tracked filings.
Where can I see all of Ashish Mandelia's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Ashish Mandelia and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial